The Role of Percutaneous Image-Guided Thermal Ablation for the Treatment of Pulmonary Malignancies.

OBJECTIVE Image-guided thermal ablation is a minimally invasive treatment option for patients with primary and secondary pulmonary malignancies. Modalities include radiofrequency ablation, microwave ablation, and cryoablation. CONCLUSION Although no large randomized studies exist comparing ablation to surgery or radiotherapy, numerous studies have reported safety and efficacy for the treatment of both primary and metastatic disease in select patients. Future studies will refine patient selection, procedural technique, and assessment for local recurrence and will evaluate long-term survival.

[1]  Ronak Talati,et al.  Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients. , 2015, Journal of vascular and interventional radiology : JVIR.

[2]  F. Abtin,et al.  Evaluating Cryoablation of Metastatic Lung Tumors in Patients - Safety and Efficacy: The ECLIPSE trial - Interim analysis at 1-Year. , 2015, Cardiology in review.

[3]  C. Bartolozzi,et al.  Long-Term Results of Radiofrequency Ablation Treatment of Stage I Non-small Cell Lung Cancer: A Prospective Intention-to-Treat Study , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  R. Salem,et al.  Percutaneous Cryoablation for the Treatment of Primary and Metastatic Lung Tumors: Identification of Risk Factors for Recurrence and Major Complications. , 2016, Journal of vascular and interventional radiology : JVIR.

[5]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[6]  J. Soh,et al.  Radiofrequency Ablation of Lung Tumors Using a Multitined Expandable Electrode: Impact of the Electrode Array Diameter on Local Tumor Progression. , 2016, Journal of vascular and interventional radiology : JVIR.

[7]  T. Vogl,et al.  Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation. , 2016, AJR. American journal of roentgenology.

[8]  A. Ravaud,et al.  Lung Tumors Treated With Percutaneous Radiofrequency Ablation: Computed Tomography Imaging Follow-Up , 2011, CardioVascular and Interventional Radiology.

[9]  A. Yamamoto,et al.  Determinants of Local Progression After Computed Tomography-Guided Percutaneous Radiofrequency Ablation for Unresectable Lung Tumors: 9-Year Experience in a Single Institution , 2010, CardioVascular and Interventional Radiology.

[10]  H. Kinoshita,et al.  Percutaneous radiofrequency ablation of lung neoplasms: a minimally invasive strategy for inoperable patients. , 2002, Journal of the American College of Surgeons.

[11]  J. Luketich,et al.  Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. , 2003, The Journal of thoracic and cardiovascular surgery.

[12]  A. Mussi,et al.  Long-term results of percutaneous radiofrequency ablation of pulmonary metastases: a single institution experience. , 2016, Interactive cardiovascular and thoracic surgery.

[13]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[14]  M. Gonen,et al.  Pulmonary thermal ablation in patients with prior pneumonectomy. , 2011, AJR. American journal of roentgenology.

[15]  A. Ravaud,et al.  Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. , 2006, Radiology.

[16]  S. Kuribayashi,et al.  Computed tomographic appearance of lung tumors treated with percutaneous cryoablation. , 2012, Journal of vascular and interventional radiology : JVIR.

[17]  K. Takeda,et al.  Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates , 2012, Japanese Journal of Radiology.

[18]  W. Moore,et al.  Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. , 2010, Journal of the American College of Surgeons.

[19]  J. Hinshaw,et al.  Optimizing the Protocol for Pulmonary Cryoablation: A Comparison of a Dual- and Triple-Freeze Protocol , 2010, CardioVascular and Interventional Radiology.

[20]  T. Baère,et al.  In Vivo Evaluation of Lung Microwave Ablation in a Porcine Tumor Mimic Model , 2013, CardioVascular and Interventional Radiology.

[21]  Young Min Han,et al.  Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. , 2004, Radiology.

[22]  Thomas J Vogl,et al.  Factors influencing local tumor control in patients with neoplastic pulmonary nodules treated with microwave ablation: a risk-factor analysis. , 2013, AJR. American journal of roentgenology.

[23]  P. Therasse,et al.  Response evaluation criteria in solid tumors (RECIST): new guidelines. , 2001, Medical and pediatric oncology.

[24]  Y. Izumi,et al.  Percutaneous Cryoablation of Pulmonary Metastases from Colorectal Cancer , 2011, PloS one.

[25]  A R Padhani,et al.  The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: implications for diagnostic radiologists. , 2001, The British journal of radiology.

[26]  D. Morris,et al.  Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer , 2004, The British journal of surgery.

[27]  N. Ikeda,et al.  Prognostic Factors After Pulmonary Metastasectomy for Colorectal Cancer and Rationale for Determining Surgical Indications: A Retrospective Analysis , 2013, Annals of surgery.

[28]  S. Toyooka,et al.  Long-term survival following percutaneous radiofrequency ablation of colorectal lung metastases. , 2015, Journal of vascular and interventional radiology : JVIR.

[29]  Carlo Bartolozzi,et al.  Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). , 2008, The Lancet. Oncology.

[30]  T. de Baère,et al.  Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. , 2011, Radiology.

[31]  J C Rosenwald,et al.  Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. , 2000, International journal of radiation oncology, biology, physics.

[32]  B. Liu,et al.  Percutaneous radiofrequency ablation for medically inoperable patients with clinical stage I non-small cell lung cancer , 2014, Thoracic cancer.

[33]  M. Beland,et al.  Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation. , 2012, European journal of radiology.

[34]  David R. Jones,et al.  Lung Adenocarcinoma: Predictive Value of KRAS Mutation Status in Assessing Local Recurrence in Patients Undergoing Image-guided Ablation. , 2017, Radiology.

[35]  S. Nehmeh,et al.  Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness. , 2013, Radiology.

[36]  S. Solomon,et al.  Ablation for the management of pulmonary malignancies. , 2011, AJR. American journal of roentgenology.

[37]  T. de Baère,et al.  Lung ablation: Best practice/results/response assessment/role alongside other ablative therapies. , 2017, Clinical radiology.

[38]  W. Travis,et al.  Ki 67 is an Independent Predictive Biomarker of Cancer Specific and Local Recurrence-Free Survival After Lung Tumor Ablation , 2013, Annals of Surgical Oncology.

[39]  Young Min Han,et al.  Comparison of Survival Rate in Primary Non-Small-Cell Lung Cancer Among Elderly Patients Treated With Radiofrequency Ablation, Surgery, or Chemotherapy , 2012, CardioVascular and Interventional Radiology.

[40]  Thomas Lehnert,et al.  Risk factors involved in the development of pneumothorax during radiofrequency ablation of lung neoplasms. , 2009, AJR. American journal of roentgenology.

[41]  T. Vogl,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. , 2014, Journal of vascular and interventional radiology : JVIR.

[42]  C. Combescure,et al.  Risk Factors for Survival after Lung Metastasectomy in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis , 2013, Annals of Surgical Oncology.

[43]  T. D. Baerea,et al.  Percutaneous thermal ablation of primary lung cancer , 2016 .

[44]  P. Catalano,et al.  Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer. , 2015, Clinical lung cancer.

[45]  H. Kinoshita,et al.  Percutaneous radiofrequency ablation of lung neoplasms: a minimally invasive strategy for inoperable patients. , 2002, Journal of the American College of Surgeons.

[46]  Xiaofei Li,et al.  Is radiofrequency thermal ablation a safe and effective procedure in the treatment of pulmonary malignancies? , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[47]  Thomas Lehnert,et al.  Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. , 2011, Radiology.

[48]  M. Høyer,et al.  Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[49]  A. Padhani,et al.  The RECIST criteria: implications for diagnostic radiologists , 2001 .

[50]  K. Takeda,et al.  Lung Radiofrequency Ablation for the Treatment of Unresectable Recurrent Non-Small-Cell Lung Cancer After Surgical Intervention , 2012, CardioVascular and Interventional Radiology.

[51]  M Buyse,et al.  Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. , 1997, The Journal of thoracic and cardiovascular surgery.

[52]  H. Takaki,et al.  Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller , 2015, International Journal of Clinical Oncology.

[53]  X. Buy,et al.  Cone-Beam Computed Tomography (CBCT) Versus CT in Lung Ablation Procedure: Which is Faster? , 2015, CardioVascular and Interventional Radiology.

[54]  S. Solomon,et al.  Treatment of pulmonary colorectal metastases by radiofrequency ablation. , 2013, Clinical colorectal cancer.

[55]  W W Mayo-Smith,et al.  Percutaneous radiofrequency ablation of malignancies in the lung. , 2000, AJR. American journal of roentgenology.

[56]  J. Utikal,et al.  Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non‐small‐cell lung cancer , 2015, Clinical and experimental immunology.

[57]  J. Zhao,et al.  Percutaneous Imaging–Guided Radiofrequency Ablation in Patients With Colorectal Pulmonary Metastases: 1-Year Follow-Up , 2004, Annals of Surgical Oncology.

[58]  K. Takeda,et al.  Detection of Local Tumor Progression by 18F-FDG PET/CT Following Lung Radiofrequency Ablation: PET Versus CT , 2013, Clinical nuclear medicine.

[59]  S. Hillman,et al.  Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome? , 2011, AJR. American journal of roentgenology.

[60]  D E Dupuy,et al.  Image-guided radiofrequency tumor ablation: challenges and opportunities--part I. , 2001, Journal of vascular and interventional radiology : JVIR.

[61]  D. Morris,et al.  Treatment Failure After Percutaneous Radiofrequency Ablation for Nonsurgical Candidates With Pulmonary Metastases From Colorectal Carcinoma , 2007, Annals of Surgical Oncology.

[62]  G. Jin,et al.  Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer. , 2012, European journal of radiology.

[63]  Takao Hiraki,et al.  Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors , 2006, Cancer.

[64]  Amita Sharma,et al.  Radiofrequency ablation of stage IA non–small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial , 2015, Cancer.

[65]  William W Mayo-Smith,et al.  Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. , 2008, Radiology.

[66]  J. Hinshaw,et al.  Temperature isotherms during pulmonary cryoablation and their correlation with the zone of ablation. , 2010, Journal of vascular and interventional radiology : JVIR.

[67]  Masanori Inoue,et al.  Percutaneous cryoablation of lung tumors: feasibility and safety. , 2012, Journal of vascular and interventional radiology : JVIR.

[68]  Y. Izumi,et al.  Percutaneous Cryoablation for the Treatment of Medically Inoperable Stage I Non-Small Cell Lung Cancer , 2012, PloS one.

[69]  J. Machan,et al.  Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more? , 2013, Journal of vascular and interventional radiology : JVIR.

[70]  D. Dupuy,et al.  Microwave Ablation for Lung Neoplasms: A Retrospective Analysis of Long-Term Results. , 2014, Journal of vascular and interventional radiology : JVIR.

[71]  H. Date,et al.  Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control? , 2008, Journal of vascular and interventional radiology : JVIR.

[72]  J. Goldin,et al.  Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results. , 2003, Radiology.

[73]  W. Lees,et al.  Early Indicators of Treatment Success After Percutaneous Radiofrequency of Pulmonary Tumors , 2009, CardioVascular and Interventional Radiology.

[74]  A. Gage,et al.  Mechanisms of tissue injury in cryosurgery. , 1998, Cryobiology.

[75]  R. Shah,et al.  Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer? , 2012, Interactive cardiovascular and thoracic surgery.

[76]  William W Mayo-Smith,et al.  Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. , 2007, Radiology.

[77]  X. Ye,et al.  Advanced non small cell lung cancer: response to microwave ablation and EGFR Status , 2017, European Radiology.

[78]  D. Dupuy,et al.  Lung Cancer Ablation: Technologies and Techniques , 2013, Seminars in Interventional Radiology.

[79]  J. Lee,et al.  Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. , 2004, AJR. American journal of roentgenology.

[80]  William R. Lees,et al.  Radiofrequency ablation of lung metastases: factors influencing success , 2008, European Radiology.

[81]  F. Abtin,et al.  Radiofrequency ablation of lung tumors: imaging features of the postablation zone. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.

[82]  Florian M Vogt,et al.  Value of CT volume imaging for optimal placement of radiofrequency ablation probes in liver lesions. , 2002, Journal of vascular and interventional radiology : JVIR.

[83]  Xia Yang,et al.  Percutaneous microwave ablation of stage I medically inoperable non‐small cell lung cancer: Clinical evaluation of 47 cases , 2014, Journal of surgical oncology.

[84]  M. Sonobe,et al.  Impact of KRAS and EGFR Gene Mutations on Recurrence and Survival in Patients with Surgically Resected Lung Adenocarcinomas , 2012, Annals of Surgical Oncology.

[85]  T. Baère,et al.  Irreversible Electroporation (IRE) Fails to Demonstrate Efficacy in a Prospective Multicenter Phase II Trial on Lung Malignancies: The ALICE Trial , 2015, CardioVascular and Interventional Radiology.

[86]  M. Beland,et al.  Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. , 2010, Radiology.

[87]  S. Toyooka,et al.  Long-Term Survival after Radiofrequency Ablation of Lung Oligometastases from Five Types of Primary Lesions: A Retrospective Evaluation. , 2016, Journal of vascular and interventional radiology : JVIR.

[88]  S. Larson,et al.  18F-FDG PET/CT for the Prediction and Detection of Local Recurrence After Radiofrequency Ablation of Malignant Lung Lesions , 2010, The Journal of Nuclear Medicine.

[89]  F. Ronza,et al.  Patients' survival in lung malignancies treated by microwave ablation: our experience on 56 patients. , 2013, European journal of radiology.

[90]  H. Hoffmann,et al.  Reported Outcome Factors for Pulmonary Resection in Metastatic Colorectal Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[91]  Xiaofei Li,et al.  CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases , 2012, World Journal of Surgical Oncology.

[92]  R. Timmerman,et al.  Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). , 2013, The Journal of thoracic and cardiovascular surgery.

[93]  X. Ye,et al.  Local Efficacy and Survival after Microwave Ablation of Lung Tumors: A Retrospective Study in 183 Patients. , 2016, Journal of vascular and interventional radiology : JVIR.

[94]  S. Kanazawa,et al.  Percutaneous radiofrequency ablation combined with previous bronchial arterial chemoembolization and followed by radiation therapy for pulmonary metastasis from hepatocellular carcinoma. , 2006, Journal of vascular and interventional radiology : JVIR.

[95]  S. Kwan,et al.  Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer. , 2014, Journal of vascular and interventional radiology : JVIR.

[96]  J. Morgan-Parkes,et al.  Metastases: mechanisms, pathways, and cascades. , 1995, AJR. American journal of roentgenology.

[97]  S. Toyooka,et al.  Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. , 2011, The Journal of thoracic and cardiovascular surgery.

[98]  T. de Baère,et al.  Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[99]  K. Hong,et al.  Percutaneous lung tumor ablation. , 2013, Techniques in vascular and interventional radiology.

[100]  S. Solomon,et al.  The role of percutaneous image-guided ablation for lung tumors , 2014, La radiologia medica.